Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trials to Assess the Efficacy and Safety of HLIM for Symptomatic Relief of Cough and Sputum in Patients With Acute Upper Respiratory Tract Infection or Acute Bronchitis

NCT03827590 is registered in ClinicalTrials.gov with SamA Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT03827590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03827590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trials to Assess the Efficacy and Safety of HLIM for Symptomatic Relief of Cough and Sputum in Patients With Acute Upper Respiratory Tract Infection or Acute Bronchitis
Lead sponsor
SamA Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Unknown status
Start date
November 29, 2018
Completion date
October 31, 2019
Enrollment
487 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute bronchitis, acute upper respiratory tract infection